FutureChem Co Ltd
Company Profile
Business description
FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.
Contact
59, Seongsuil-ro
3rd Floor, B-dong, Pyeonghwa Building
Seoul04782
KORT: +82 24973114
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
89
Stocks News & Analysis
stocks
Lower production and higher prices for ASX hydrocarbon play
stocks
Alphabet returns on AI investments accelerating
stocks
We lift our fair value estimate for this ASX energy play
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,863.60 | 6.90 | -0.08% |
| CAC 40 | 8,072.13 | 31.96 | -0.39% |
| DAX 40 | 23,954.56 | 63.70 | -0.27% |
| Dow JONES (US) | 48,861.81 | 280.12 | -0.57% |
| FTSE 100 | 10,213.11 | 119.68 | -1.16% |
| HKSE | 25,789.59 | 322.25 | -1.23% |
| NASDAQ | 24,673.24 | 9.44 | 0.04% |
| Nikkei 225 | 59,087.74 | 829.72 | -1.38% |
| NZX 50 Index | 12,846.35 | 76.05 | 0.60% |
| S&P 500 | 7,135.95 | 2.85 | -0.04% |
| S&P/ASX 200 | 8,641.70 | 1.50 | 0.02% |
| SSE Composite Index | 4,111.02 | 3.50 | 0.09% |